Additional information was received contesting the scientific assessment set out in the RAC opinions of 11 June 2020 concerning 2-ethylhexanoic acid and its salts; of 11 June 2020 concerning a reassessment at the request of the European Commission of the developmental toxicity of N-carboxymethyliminobis (ethylenenitrilo)tetra(acetic acid) (DTPA) and its pentasodium and pentapotassium salts; of 8 October 2020 concerning ammonium bromide; of 10 December 2020 concerning divanadium pentaoxide; of 10 December 2020 concerning a reassessment at the request of the European Commission of the new information on acute inhalation toxicity of 2-butoxyethanol; ethylene glycol monobutyl ether (EGBE); and of 10 December 2020 concerning melamine.
Recital 3, Regulation (EU) 2022/692
In forcesince 16 Feb 2022cited 1×
Judgment of the General Court (Sixth Chamber) of 27 November 2024. BASF SE and Others v European Commission.Decision
Lastly, it is apparent from recitals 3 and 4 of the contested regulation that the Commission considered that other additional information, received following the additional RAC opinion, was not sufficient to cast doubt on the scientific …
27 Nov 2024 · 62022TJ0453